Straumann Group (STMN) investor relations material

Executive summary

• CEO to step down at year-end after 20 years, with Christopher Norbye appointed as successor, ensuring a smooth handover and continuity of strategy.

• H1 2026 revenue reached CHF 1.4 billion, with Q2 organic growth of 8.5% and H1 organic growth of 7.8%.

• Strong operational leverage from manufacturing productivity, supply chain optimization, and disciplined OPEX management.

• Digital solutions, especially IOS, SIRIOS X3, and iEXCEL, drove double-digit revenue growth and market share gains.

• Premium implantology, digital solutions, and orthodontics were key growth drivers, with Neodent's global expansion contributing.

Financial highlights

• Q2 revenue reached CHF 707 million, bringing H1 revenue to CHF 1.4 billion (organic growth 7.8%, reported 2.3%).

• Core EBIT margin improved to 26.9% at constant 2025 FX, or 25.7% including currency effects, up 90 bps year-over-year.

• Core gross profit was CHF 972 million (core gross margin 70.5%); IFRS gross margin was 72.0%.

• Core net profit reached CHF 262 million (margin 19%), up 15.7% year-over-year; IFRS net profit margin was 18.2%.

• Free cash flow increased 49% to CHF 169 million (12.2% of net revenue); CAPEX was CHF 74 million (5.4% of revenue), down from CHF 113 million prior year.

Outlook and guidance

• Upgraded full-year 2026 guidance: high single-digit organic revenue growth and core EBIT margin improvement of 140–170 basis points at constant 2025 FX.

• 2030 margin ambition remains unchanged, with sustainable improvements expected to continue.

• Profitability improvement expected to be evenly distributed between H1 and H2 2026.

• Confident in ability to deliver midterm guidance, supported by management alignment and strong execution.

• Significant growth opportunities in a CHF 20bn+ addressable market.